Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2000, p. 2905-2907, Vol. 44, No. 10
Department of Microbiology and Immunology,
Stanford University School of Medicine, Sherman Fairchild D317,
Stanford, California 94305
Received 27 April 2000/Returned for modification 13 June
2000/Accepted 26 June 2000
EmrR negatively regulates the transcription of the multidrug
resistance pump-encoding operon, emrRAB, by binding to its
regulatory region. The binding site spans the promoter and the
downstream sequence up to the transcriptional start site of the operon.
Structurally unrelated drugs that induce the pump interfere with this binding.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The EmrR Protein Represses the Escherichia
coli emrRAB Multidrug Resistance Operon by Directly Binding to
Its Promoter Region
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Stanford University School of Medicine, Sherman Fairchild D317, Stanford, CA 94305. Phone: (650) 725-4745. Fax:
(650) 725-6757. E-mail:
a.matin{at}forsynthe.stanford.edu.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |